Author Correction: Dolutegravir restores gut microbiota in late-stage HIV-1 unlike darunavir: an open-label, randomized clinical trial.
- DOI
- 10.1038/s41467-026-72458-w
- Published
- 2026 Apr 27
- Container
- Nature communications
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/s41467-026-72458-w,
title = {Author Correction: Dolutegravir restores gut microbiota in late-stage HIV-1 unlike darunavir: an open-label, randomized clinical trial.},
author = {Català-Moll F and Blázquez-Bondia C and Farré-Badia J and Torres F and Manzardo C and Bonfill E and Curran A and Domingo P and Podzamczer D and Force L and Falcó V and Parera M and Casadellà M and Miró JM and Noguera-Julian M and Paredes R and ADVANZ-4 MISTRAL investigators},
year = {2026},
journal = {Nature communications},
doi = {10.1038/s41467-026-72458-w},
url = {https://doi.org/10.1038/s41467-026-72458-w}
}RIS
TY - JOUR TI - Author Correction: Dolutegravir restores gut microbiota in late-stage HIV-1 unlike darunavir: an open-label, randomized clinical trial. AU - Català-Moll F AU - Blázquez-Bondia C AU - Farré-Badia J AU - Torres F AU - Manzardo C AU - Bonfill E AU - Curran A AU - Domingo P AU - Podzamczer D AU - Force L AU - Falcó V AU - Parera M AU - Casadellà M AU - Miró JM AU - Noguera-Julian M AU - Paredes R AU - ADVANZ-4 MISTRAL investigators PY - 2026 JO - Nature communications DO - 10.1038/s41467-026-72458-w UR - https://doi.org/10.1038/s41467-026-72458-w ER -
APA
F, C., C, B., J, F., F, T., C, M., E, B., A, C., P, D., D, P., L, F., V, F., M, P., M, C., JM, M., M, N., R, P., & investigators, A. M. (2026). Author Correction: Dolutegravir restores gut microbiota in late-stage HIV-1 unlike darunavir: an open-label, randomized clinical trial.. Nature communications. https://doi.org/10.1038/s41467-026-72458-w
Source records
- pubmed · retrieved 2026-09-25T22:57:57.890Z